Thrombocytosis is a marker of reduced survival in patients with renal cell carcinoma.: A multicenter study. REV SEN [Internet]. 2022 Feb. 28 [cited 2026 Apr. 16];10(1):43-8. Available from: https://www.rev-sen.ec/index.php/revista/article/view/11